Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Cash from Investing Activities (2018 - 2025)

Historic Cash from Investing Activities for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to -$674000.0.

  • Bicycle Therapeutics' Cash from Investing Activities fell 5494.25% to -$674000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year decrease of 13355.12%. This contributed to the annual value of -$1.2 million for FY2024, which is 5783.54% up from last year.
  • Per Bicycle Therapeutics' latest filing, its Cash from Investing Activities stood at -$674000.0 for Q3 2025, which was down 5494.25% from -$498000.0 recorded in Q2 2025.
  • Bicycle Therapeutics' 5-year Cash from Investing Activities high stood at -$12000.0 for Q1 2024, and its period low was -$9.8 million during Q2 2022.
  • For the 5-year period, Bicycle Therapeutics' Cash from Investing Activities averaged around -$1.4 million, with its median value being -$502000.0 (2023).
  • In the last 5 years, Bicycle Therapeutics' Cash from Investing Activities crashed by 563040.94% in 2022 and then skyrocketed by 9942.83% in 2024.
  • Over the past 5 years, Bicycle Therapeutics' Cash from Investing Activities (Quarter) stood at -$1.1 million in 2021, then crashed by 35.71% to -$1.4 million in 2022, then skyrocketed by 96.48% to -$51000.0 in 2023, then crashed by 621.57% to -$368000.0 in 2024, then crashed by 83.15% to -$674000.0 in 2025.
  • Its Cash from Investing Activities stands at -$674000.0 for Q3 2025, versus -$498000.0 for Q2 2025 and -$604000.0 for Q1 2025.